Yahoo HomeDeshaun Watson requests trade from Texans
Deshaun Watson requests trade from Texans
Make Yahoo Your Homepage
Discover something new every day from News, Sports, Finance, Entertainment and more!
Deshaun Watson requests trade from Texans
Renee Montgomery is among the few women to own a professional sports team.
No word on who will be cast as the Kryptonian hero in new DC film but Michael B. Jordan had explored playing a Black Superman before and the internet has just nominated John Boyega.
(Bloomberg) -- GameStop Corp. shares are on track for their best week this month amid a flurry of day trader activity.The video-game retailer has jumped about 200% so far this week, as it staged another late afternoon rebound as amateur investors continued to promote the stock on social media platforms like Reddit and StockTwits. More than 75 million shares changed hands heading into the final hour of trading, more than triple what’s been seen in the past two weeks, and adding to the 233 million that traded over the past two sessions.“It would be unwise to discount the power of the collective retail trade and this is an example of the resurgence of energy either on GME again or through another stock,” said Amy Kong, chief investment officer of Barrett Asset Management.The stock has been a poster child for volatility so far this year. Euphoria for the video-game retailer set off a 2,728% rally last month before shares came crashing down and wiped out about $30 billion in market value. The retail craze drew ire from Washington and led to a House Financial Services Committee hearing on retail trading and the video-game distributor last week.Options traders were betting that the stock could do much better Friday after more than doubling so far this week. The most-active option traded on the stock Thursday was a contract on GameStop spiking to $800 on Friday. Some 52,000 contracts changed hands during the session betting on this one-day gain of 636%. The stock rebounded to rise 9.1% to $119 as of 2:56 p.m. in New York after swinging between a 31% jump and 21% slide.“From a top-down perspective, I would caution that these price spikes continue to signal frothiness in certain corners of the market and represent sharp deviations from company fundamentals,” Kong said.Analysts cited a tweet by activist investor and GameStop board member Ryan Cohen posted shortly before the stock began its resurgence on Wednesday, suggesting Reddit traders may view the photo of a McDonald’s Corp. ice cream as a cryptic message to resume buying. A report from Citron Research suggesting the company purchase Esports Entertainment Group Inc. to pivot away from its declining retail business provided a further catalyst.Even with the stock volatility on Friday, shares remain nearly nine-times higher than the average analyst price target of about $13, according to data compiled by Bloomberg. None of the eight analysts who follow the stock rate it a buy -- it has four hold-equivalents and four sell recommendations.While the stock’s revival caught many on Wall Street flat-footed this week, the craze is “nothing like what we saw in late January,” according to Eric Liu, the co-founder of Vanda Research. “Part of that is due to a broadening of the opportunity set” with retail traders flowing into cannabis and crypto-exposed companies, he said in an email.(Updates share price moves throughout.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
When the Knicks announced that Elfrid Payton would miss Thursday night's game against the Sacramento Kings, we knew that the other point guards on the team were going to have to step it up.
It seems Americans can’t get enough oat milk of late. Dogfish Head, the Delaware-based brewer that’s now owned by the maker of Sam Adams beer and has become one of the major names in the world of craft beer, recently introduced Hazy-O!, a product that’s indeed made with oat milk. Dogfish founder Sam Calagione says he was noting how popular the plant milk was becoming and thought it might be the “perfect ingredient” for a hazy IPA, a style of IPA that’s less bitter.
Even as the virus slows nationwide, nursing home cases have dropped at a faster pace than COVID-19 infections overall, a USA TODAY analysis shows.
Chile's state-owned Codelco, the world's largest copper producing company, on Friday reported 2020 profits of more than $2 billion -- 55 percent higher than the previous year despite the coronavirus pandemic.
CHARLOTTESVILLE, Va., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial”), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will host a Town Hall at 1 P.M., Eastern Time on Thursday, March 18, 2021. Information for shareholders interested in attending will be available at the Company’s Investors section of the website: https://ir.adialpharma.com/ About Adial Pharmaceuticals, Inc. Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company’s landmark ONWARD™ pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company’s proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity, and the Company develops adenosine analogs for the treatment of pain and other disorders. Additional information is available at www.adialpharma.com. About the Landmark ONWARD™ Pivotal Phase 3 Clinical Trial The ONWARD trial is a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel group, Phase 3 clinical study to evaluate the efficacy, safety and tolerability of AD04 in patients with Alcohol Use Disorder (AUD) and selected polymorphisms in the serotonin transporter and receptor genes. Patients are genetically screened prior to enrollment in the ONWARD trial so that only genetically positive patients are enrolled. The primary endpoint for analysis of efficacy is the change from baseline in the monthly number of heavy drinking days during the last 8 weeks of the 24-week treatment period. ONWARD is currently being conducted in 25 clinical sites in seven countries in Scandinavia and Central and Eastern Europe (Sweden, Finland, Poland, Latvia, Estonia, Bulgaria and Croatia). The principal investigator is Professor Hannu E.R. Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki. Note on Forward-looking Statements This communication contains certain "forward-looking statements" within the meaning of the U.S. federal securities laws. Such statements are based upon various facts and derived utilizing numerous important assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could" are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. The forward-looking statements include statements regarding the potential of AD04 to treat other addictive disorders such as opioid use disorder, gambling, and obesity. Any forward-looking statements included herein reflect our current views, and they involve certain risks and uncertainties, including, among others, our ability to enroll patients within the timelines anticipated and complete clinical trials on time and achieve desired results and benefits as expected, our ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to our ability to promote or commercialize our product candidates for specific indications, acceptance of its product candidates in the marketplace and the successful development, marketing or sale of products, our ability to maintain our license agreements, the continued maintenance and growth of our patent estate, our ability to establish and maintain collaborations, our ability to obtain or maintain the capital or grants necessary to fund its research and development activities, and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive and should be read together with the other cautionary statement included in our Annual Report on Form 10-K for the year ended December 31, 2019, subsequent Quarterly Reports on Form 10-Q and current reports on Form 8-K filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it was initially made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise, unless required by law. Contact: Crescendo Communications, LLCDavid Waldman / Natalya RudmanTel: 212-671-1021Email: dwaldman@crescendo-ir.com
Cority solidifies leadership in EHS software market with record-breaking revenue growth, global expansion, and product innovationToronto, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cority, the global enterprise EHS software provider, today announced record growth and global expansion in 2020. The company’s continued momentum was driven by the highest sales bookings in company history, industry-leading COVID-19 pandemic response solutions, new appointments to the leadership team, and a strategic acquisition. “Now more than ever, we’re seeing organizations double down on their commitment to employee health, safety, and well-being, which has contributed to the exceptional growth we’ve experienced this past year,” said Mark Wallace, President and CEO, Cority. “We’re proud to support our clients’ ongoing pandemic responses with our industry-leading occupational health and COVID-19 solutions, enabling them to mitigate risk, improve compliance, and empower better outcomes. Our team is continuing to innovate rapidly to keep pace with growing demand for our software, enhance our core platform, and deliver best-in-class solutions to our global clients.” Highlights of the year include: Acquisition of Enviance – Coming on the heels of the Axion Health acquisition, Cority added over 400 clients and best-in-class environmental, chemical management, sustainability, and ergonomics solutions to its SaaS platform with the acquisition of Enviance. Unparalleled Market Momentum – Cority continued to demonstrate strong and profitable growth with record-breaking new sales bookings. The company’s momentum was reaffirmed in the Green Quadrant EHS Software 2021 by independent analyst firm Verdantix. Cority was recognized as a Leader for the fourth consecutive year and earned the highest overall score in the Market Momentum category. Pandemic Response – In response to the COVID-19 pandemic, Cority released its turnkey COVID-19 Return to Work and Productivity and Hazard Management & Workforce engagement SaaS solutions, which enable organizations to rapidly operationalize their pandemic response plans, systematically monitor and report on the health status of employees, and streamline a safe and efficient return to operations. Over 200 organizations globally are leveraging Cority’s solutions to navigate the pandemic. Product Innovation – Cority released CorInsights, a predictive data analytics solution that provides organizations with immediate and meaningful, point-in-time insights to help reduce risk and drive better business outcomes. To accelerate the future of connected EHS management, Cority announced partnerships with Interaptix, Highmark Interactive, and TapRooT. To enable hospitals and healthcare providers to streamline clinical operations and improve business performance, Cority launched its Occupational Medicine solution. Cority also made significant enhancements to its risk management capabilities and emissions calculation functionality. Leadership Team Appointments – To accelerate Cority’s next phase of growth, product innovation, and deliver exceptional customer experiences, Cority strengthened its leadership team with the hiring of Stephen Molen, Chief Revenue Officer, and Atish Ghosh, Chief Technology Officer. Industry Accolades – in addition to Cority’s positioning in the Green Quadrant for EHS Software, Cority was the recipient of several industry awards including Occupational Health & Safety’s New Product of the Year Award, ISHN's Readers’ Choice Awards, Environment + Energy Leader’s Top Product of the Year Award, and Environmental Protection’s New Product of the Year Award. Global Expansion – Cority continued to expand its global footprint and announced a partnership with VP&White to support the delivery of large-scale Cority software implementations across Europe. Additionally, Cority announced expanded partnerships with RegScan and Verisk 3E. Customer Success and Community – Attendance at Cority’s sold-out annual user group conference, Cority Connect, increased by over 20% and brought close to 500 environmental, health, and safety practitioners together for three days of thought leadership and expert-led training in Nashville, TN. Cority also launched a new online Community to further support its rapidly growing client base with access to informative and interactive resources designed to drive program success. Cority is hosting its first-ever virtual Cority Connect March 3-4, 2021. To learn more about the event and reserve your spot, visit www.corityconnect.com About CorityCority is the global enterprise EHS software provider creating industry-leading technology to empower those who transform the way the world works. For over 35 years, Cority has been powered by a spirit of innovation, deep domain expertise, and a commitment to integrity that enables higher levels of operational and sustainable performance with the most comprehensive, human-centered, and secure SaaS platform to help people and businesses thrive around the world. The company enjoys the industry’s highest levels of client satisfaction and has received many awards for its strong employee culture and outstanding business performance. To learn more, visit www.cority.com. CONTACT: Cority Software Inc. media@cority.com
A boatman built a water ambulance to ferry sick people across a lake to hospital This floating ambulance connects rural Kashmiris to hospitals This man answers calls in the dead of night to transport sick people across a lake to a hospital
The Internal Revenue Service is implementing the 8,000 page 2021 Covid-19 CARES Act that was rushed out by Congress on December 21, 2021. Buried in the bill is a great financial relief package for U.S. small businesses – the 2021 CARES Act Employee Retention Tax Credits (ERC).
Feb. 26—Alejandro Montoya Marín has taken plenty of projects from page to screen. With "The Sequel to Monday (Tuesday)," he's taking one back to the page. The Albuquerque-based director was looking to keep himself busy while on hiatus from the film industry due to the pandemic. Coming off his independent features "Millennium Bugs" and "Monday," he looked for a change. A few years ago, Montoya ...
The GameStop rally could herald a rise in “noise trader risk,” potentially driving rational traders from obscure, less liquid corners of the stock market and stoking increased volatility, warns one quantitative analyst.
The follow-up to 2019's 'Lessons In Love' will also feature last year's EARTHGANG-assisted "Take Me Away" and "Stickin'" with Masego and VanJess.
Feb. 26—SANTA FE, N.M. — The man convicted of murdering a 75-year-old Santa Fe man and then burning his body had his "warrior gene" defense rejected yet again by the New Mexico Supreme Court. The New Mexico Supreme Court last week upheld Anthony Blas Yepez's 22 1/2 year sentence for the murder of George Ortiz in 2012. Yepez was found guilty in 2015 by a Santa Fe jury for second-degree murder, ...
SportsPulse: The Atlanta Dream and WNBA officially cut any ties with Kelly Loeffler with the sale of the team this week. As Dan Wolken explains, the relationship between Loeffler and the league was always going to be an untenable situation.
What can we learn from the best 40 venture capital investments of all time? Of the 43 U.S.-based founders, 35 were white American; four were white immigrant/first generation, from France, Ukraine, Russia and Iran; and four were Indian immigrant/first generation.
Jim Bourg/ReutersA senior Justice Department official opened the door to seeking new legislative authorities to pursue domestic terrorism, a step the Biden administration has yet to entertain since the January 6 insurrection and something civil libertarians have warned against.The prospect of expanded investigative and prosecutorial tools arose during a Friday briefing with reporters in which multiple Justice Department and FBI officials described an expansive array of authorities already available to them.While there is no domestic terrorism statute, and U.S. officials can not designate a domestic group for sanction like they can a foreign one, one senior official acknowledged that statutory definitions of domestic terrorism “expand a lot of authorities we can use,” such nationwide search warrants, expanded law-enforcement access to tax and educational records, and harsher sentencing.First Capitol Riot Hearing Only Raised More Questions About Jan. 6But on Friday, a senior Justice Department official suggested the administration would consider seeking a domestic-terrorism statute as well.“Obviously that’s going to be a policy question for the folks that are coming in” to the administration, said the senior official. “I’m sure we’ll run a data-driven process to see whether we need additional legislative authorities in this area.”That has been a step the new administration has yet to take. On Tuesday, Sen. Mark Warner, the Virginia Democrat who chairs the Senate intelligence committee, told The Daily Beast’s “New Abnormal” podcast that the FBI has not sought additional powers to confront white supremacist or far-right violence. The FBI did not challenge that characterization, telling The Daily Beast: “The FBI defers to the legislative branch to work with leadership at the Department of Justice on whether any additional legislation is required.”The prospect of new counterterrorism powers has alarmed civil libertarians and others who fear that such authorities are both unnecessary and rife for abuse to criminalize extreme political views, rather than pursue people who have planned or committed acts of violence. Pointing to the excesses of the FBI during the 20-year War on Terror, they also fear that expanding those law enforcement, intelligence and prosecutorial powers will permit future presidents to use them against marginalized groups. Former President Donald Trump, for instance, slandered Black Lives Matter activists as terrorists.“We should not lose sight of our disgust at the double standards employed against white protesters and Black ones, or against Muslims and non-Muslims,” Rep. Ilhan Omar (D-MN) told The Daily Beast in the week after the Capitol insurrection. “But at the same time, we must resist the very human desire for revenge—to simply see the tools that have oppressed Black and Brown people expanded… The answer is not more laws expanding the surveillance and security state.”Three Percenter Truck at Capitol on Jan. 6 Belongs to Hitler-Quoting Rep’s HusbandOn the call, Acting Deputy Attorney General John Carlin pledged that the Justice Department was “prioritizing the detection, disruption and deterrence of domestic terrorism and violent extremism in all its forms.” Carlin repeatedly referenced continuities in such prioritization with the post-9/11 pursuit of jihadist terror at home, such as taking an “intelligence-led” approach, “as we have since 9/11.”Across the government, and to include Director of National Intelligence Avril Haines’ forthcoming “comprehensive threat assessment” of domestic terrorism, Carlin said the administration was looking at expanding information sharing, to prevent radicalization and disrupt “extremist networks.” As many officials have since 9/11, Carlin promised the protection of civil liberties would remain a priority.Carlin said the Justice Department would soon issue guidance ensuring its National Security Division “has insight into and can track all cases with a nexus to domestic terrorism” or violent extremism, in the hope of generating leads in cases across jurisdictions.“This approach recognizes that success is not the prosecution of a violent extremist or terrorist after the fact when families have lost loved ones and are grieving,” Carlin said. “Success is a disruption before violence occurs and that always has to be the goal of our counterterrorism work.”Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.
Brazilian prosecutors are seeking the immediate suspension of purchases of India's COVID-19 vaccine COVAXIN, according to a document seen by Reuters on Friday, one day after the health ministry signed a contract to purchase 20 million doses. The vaccine made by private Indian company Bharat Biotech has yet to be backed up with Phase III clinical trial results, the prosecutors at the Federal Audit Court, known as the TCU, argued in seeking an injunction. The health ministry did not immediately respond to a request for comment.
Saudi Arabia's de facto ruler approved an operation to capture or kill murdered journalist Jamal Khashoggi in 2018, according to a U.S. intelligence assessment released on Friday as the United States sanctioned some of those involved but not the crown prince himself. Khashoggi, a U.S. resident who wrote opinion columns for the Washington Post critical of Crown Prince Mohammed bin Salman's policies, was killed and dismembered by a team of operatives linked to the prince in the kingdom's consulate in Istanbul. Riyadh has denied any involvement by the crown prince.